Table 2 Logistic regression analysis of Ln-transformed and RA, NHANES 2011–2018 analyses.

From: Association between urinary volatile organic compounds metabolites and rheumatoid arthritis among the adults from NHANES 2011–2018

Exposure

Model I

Model II

Model III

OR (95%CI)

p

OR (95%CI)

p

OR (95%CI)

p

Ln(2MHA)

1.05 (0.93–1.18)

0.414

1.15 (1.01–1.32)

0.032

1.15 (1.00-1.31)

0.042

Ln(3,4-MA)

1.05 (0.94–1.17)

0.419

1.08 (0.95–1.22)

0.261

1.08 (0.95–1.23)

0.252

Ln(AAMC)

1.08 (0.95–1.24)

0.257

1.24 (1.06–1.47)

0.009

1.24 (1.05–1.47)

0.012

Ln(AMCC)

1.30 (1.14–1.48)

0.000

1.24 (1.06–1.45)

0.007

1.23 (1.05–1.44)

0.009

Ln(ATCA)

1.04 (0.90–1.19)

0.617

1.06 (0.91–1.23)

0.474

1.06 (0.91–1.23)

0.434

Ln(BMAC)

1.02 (0.89–1.16)

0.797

0.96 (0.83–1.11)

0.575

0.95 (0.82–1.100

0.523

Ln(CEMC)

1.33 (1.15–1.53)

0.000

1.23 (1.05–1.44)

0.012

1.22 (1.04–1.44)

0.015

Ln(CYMC)

1.04 (0.98–1.11)

0.195

1.14 (1.05–1.23)

0.002

1.13 (1.04–1.23)

0.003

Ln(DHBC)

1.39 (1.14–1.69)

0.001

1.28 (1.03–1.59)

0.029

1.27 (1.01–1.58)

0.037

Ln(HP2C)

1.06 (0.93–1.20)

0.386

1.09 (0.95–1.25)

0.221

1.09 (0.95–1.25)

0.221

Ln(HPMC)

1.11 (0.98–1.27)

0.097

1.22 (1.05–1.41)

0.010

1.20 (1.03–1.40)

0.016

Ln(MADA)

1.10 (0.94–1.29)

0.220

1.14 (0.95–1.36)

0.163

1.12 (0.94–1.35)

0.213

Ln(MB3C)

1.13 (1.01–1.26)

0.040

1.17 (1.02–1.34)

0.028

1.15 (1.00-1.33)

0.045

Ln(PHGA)

1.18 (1.01–1.39)

0.042

1.12 (0.92–1.35)

0.252

1.11 (0.92–1.35)

0.268

Ln(PMMC)

1.16 (1.02–1.32)

0.021

1.15 (0.98–1.33)

0.080

1.14 (0.98–1.32)

0.101

  1. Model I did not adjust for any covariates.
  2. Model II adjusted age, gender, education, race, hypertension, diabetes, alcohol, smoke, BMI.
  3. Model III adjusted for all covariates, included age, gender, education, race, hypertension, diabetes, alcohol, smoke, BMI, ALB, ALT, AST, ALP, GGT, TB, BUN, Cr.
Back to article page